Raymond James Financial
MRK icon

Raymond James Financial’s Merck MRK Stock Holding History

Raymond James Financial’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-6,100
Closed -$580K – 4905
2024
Q4 		$580K Buy
+6,100
New +$629K ﹤0.01% 3811

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Raymond James Financial's MRK Position: Q2 2026 in Review

Raymond James Financial reduced its Merck (MRK) stake by 5.3% in Q2 2026, selling an estimated $40.8M and leaving 6,236,773 shares worth $801M. The position accounts for 0.22% of the portfolio, ranked #78.

Raymond James Financial first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.56B in Q4 2024. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Raymond James Financial held 6,236,773 shares of Merck worth $801M as of Q2 2026.
  • Raymond James Financial sold 348,741 Merck shares in Q2 2026, an estimated $40.8M.
  • Merck made up 0.22% of Raymond James Financial's portfolio in Q2 2026, its #78 holding.
  • Raymond James Financial first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Merck position peaked at $1.56B in Q4 2024.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.